47 institutions hold shares in Isoray Inc. (ISR), with 1.1M shares held by insiders accounting for 0.78% while institutional investors hold 6.20% of the company’s shares. The shares outstanding are 141.20M, and float is at 139.80M with Short Float at 2.04%. Institutions hold 6.16% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 2.79 million shares valued at $1.26 million. The investor’s holdings represent 1.98% of the ISR Shares outstanding. As of Dec 30, 2020, the second largest holder is Renaissance Technologies, LLC with 1.35 million shares valued at $0.61 million to account for 0.96% of the shares outstanding. The other top investors are Blackrock Inc. which holds 1.16 million shares representing 0.82% and valued at over $0.52 million, while Perkins Capital Management, Inc. holds 0.35% of the shares totaling 0.5 million with a market value of $0.23 million.
Isoray Inc. (AMEX: ISR) is 144.44% higher on its value in year-to-date trading and has touched a low of $0.35 and a high of $2.81 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ISR stock was last observed hovering at around $1.13 in the last trading session, with the day’s loss setting it -0.03% off its average median price target of $1.90 for the next 12 months. It is also 63.33% off the consensus price target high of $3.00 offered by 3 analysts, but current levels are -175.0% lower than the price target low of $0.40 for the same period.
Currently trading at $1.10, the stock is -8.18% and -22.96% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.34 million and changing -2.65% at the moment leaves the stock 29.26% off its SMA200. ISR registered 120.04% gain for a year compared to 6-month gain of 96.67%. The firm has a 50-day simple moving average (SMA 50) of $1.2891 and a 200-day simple moving average (SMA200) of $0.9389.
The stock witnessed a 1.85% loss in the last 1 month and extending the period to 3 months gives it a 107.35%, and is 1.85% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.68% over the week and 9.37% over the month.
Isoray Inc. (ISR) has around 53 employees, a market worth around $147.21M and $9.90M in sales. Profit margin for the company is -33.60%. Distance from 52-week low is 212.50% and -60.85% from its 52-week high. The company has generated returns on investments over the last 12 months (-61.00%).
Isoray Inc. (ISR) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Isoray Inc. (ISR) is a “Overweight”. 3 analysts offering their recommendations for the stock have an average rating of 2.00, where 1 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Isoray Inc. is expected to release its quarterly report on 09/22/2021 and quarterly earnings per share for the current quarter are estimated at -$0.01 with sales reaching $2.43M over the same period.The EPS is expected to grow by 33.50% this year, but quarterly earnings will post 0.60% year-over-year.
Isoray Inc. (ISR) Insider Activity
A total of 14 insider transactions have happened at Isoray Inc. (ISR) in the last six months, with sales accounting for 0 and purchases happening 14 times. The most recent transaction is an insider purchase by Woods Lori A, the company’s CEO. SEC filings show that Woods Lori A bought 68,000 shares of the company’s common stock on Nov 30 at a price of $0.38 per share for a total of $25534.0. Following the purchase, the insider now owns 0.61 million shares.
Isoray Inc. disclosed in a document filed with the SEC on Oct 22 that Austin Mark John (Controller/Prin Fin&Acct Offic) bought a total of 19,230 shares of the company’s common stock. The trade occurred on Oct 22 and was made at $0.52 per share for $10000.0. Following the transaction, the insider now directly holds 35230.0 shares of the ISR stock.
Still, SEC filings show that on Oct 22, Krachon Michael (EVP of Sales & Marketing) acquired 28,844 shares at an average price of $0.52 for $14999.0. The insider now directly holds 83,844 shares of Isoray Inc. (ISR).
Isoray Inc. (ISR): Who are the competitors?
The company’s main competitors (and peers) include AngioDynamics Inc. (ANGO) that is trading 130.69% up over the past 12 months and Hologic Inc. (HOLX) that is 103.29% higher over the same period. Varian Medical Systems Inc. (VAR) is 70.16% up on the 1-year trading charts. Short interest in the company’s stock has fallen -15.79% from the last report on Mar 14, 2021 to stand at a total of 2.86 million short shares sold with a short interest ratio of 0.37.